University of Pittsburgh CTSI Launches Self-Service Studies via THREAD’s Fully Configurable Technology Platform
Collaboration Pioneers No-code, Fully Configurable eClinical Technology for Academic Research at Enterprise Scale
PITTSBURGH, P.A. SEPTEMBER 10, 2024 – The University of Pittsburgh Clinical and Translational Science Institute (Pitt CTSI) launched its first-round self-service health science studies using Thread’s decentralized research platform. The two organizations reached this milestone after forming an enterprise partnership in 2023 to transform and modernize clinical research at the University.
“This is an exciting milestone in the Pitt CTSI-Thread partnership. In addition to bringing value to participants and researchers through the use of next generation eClinical technology, we are demonstrating that we can effectively scale this technology across Pitt’s extensive research portfolio,” said Dr. Steven Reis, director, Pitt CTSI.
Pitt CTSI is collaborating with Thread to design, launch and manage their research studies. Thread’s consultants provide training and education to enable study teams to independently implement clinical studies by engaging Thread’s technology solutions including eConsent, telehealth, engagement solutions, sensors, and complex eCOA. Pitt CTSI expects to launch over 400 self-service research studies on Thread’s decentralized platform.
“We’ve been committed to self-service configurable eClinical technology since our inception,” said John Reites, CEO of Thread. “We are proud to be partnering with an innovative organization like Pitt CTSI that is realizing the value of self-service digital clinical research at scale to provide the best experience to their researchers and participants.”
Thread’s range of consulting services enables research organizations to select a service approach that best supports their team and budget. Sponsors considering a self-service technology solution for their eCOA and decentralized research approaches can contact Thread or click here: https://www.threadresearch.com/services to learn more.
About University of Pittsburgh CTSI
The University of Pittsburgh Clinical and Translational Science Institute (CTSI) was launched in 2006 as one of the 12 inaugural Clinical and Translational Science Award (CTSA) Hubs funded by the National Institutes of Health. CTSI serves as the academic home for the University’s six health sciences schools and UPMC, one of the nation’s largest and most financially successful academic health care systems. CTSI supports clinical and translational science by providing resources, training, and opportunities to facilitate the planning, conduct, dissemination, and implementation of research from the bench to the bedside. In addition, CTSI emphasizes research reciprocity and has strong working partnerships with community organizations that span diverse geographic areas, racial and ethnic groups, and social affinity organizations. Pitt CTSI also has a distinguished history of successfully training students, residents, postdoctoral fellows, and junior faculty in clinical and translational science and supporting their career development.
About Thread
Thread’s® purpose is to leverage its decentralized research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites and study teams. Through its comprehensive platform and scientific expertise, Thread empowers studies to be accessible, efficient and centered on the participant. Backed by health care investors Water Street Healthcare Partners and JLL Partners, Thread is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022/2023 and positioned in the Leader's Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit Threadresearch.com to learn more.